good wiki

Drugs for Neglected Diseases Initiative

The Drugs for Neglected Diseases initiative (DNDi) is a collaborative, patients' needs-driven, non-profit drug research and development (R&D) organization that is developing new treatments for neglected diseases, notably leishmaniasis, sleeping sickness (human African trypanosomiasis, HAT), Chagas disease, malaria, filarial diseases, mycetoma, paediatric HIV, cryptococcal meningitis, hepatitis C, and dengue. DNDi's malaria activities were transferred to Medicines for Malaria Venture (MMV) in 2015.

More at Wikipedia

About

You might be interested in

African trypanosomiasis

African trypanosomiasis, also known as sleeping sickness, is a tropical disease caused by parasites of the Trypanosoma genus.

Artemisinin

Artemisinin is a compound derived from the plant Artemisia annua, commonly known as sweet wormwood.

Chagas disease

Chagas disease, also known as American trypanosomiasis, is a parasitic infection caused by the protozoan parasite Trypanosoma cruzi.

Cipla

Cipla Limited is an Indian multinational pharmaceutical company headquartered in Mumbai, Maharashtra, India.

Direct-acting antivirals

The term Direct-acting antivirals (DAA) has long been associated with the combination of antiviral drugs used to treat hepatitis C infections.

Duke University

Duke University is a private research university located in Durham, North Carolina, United States.

European Medicines Agency

The European Medicines Agency (EMA) is an agency of the European Union (EU) in charge of the evaluation and supervision of pharmaceutical products.

HIV

HIV, or Human Immunodeficiency Virus, is a retrovirus that attacks the immune system of humans, leading to the acquired immunodeficiency syndrome (AIDS).